Home » Stocks » MEDP

Medpace Holdings, Inc. (MEDP)

Stock Price: $159.02 USD -2.09 (-1.30%)
Updated Feb 25, 2021 4:00 PM EST - Market closed
Market Cap 5.78B
Revenue (ttm) 925.93M
Net Income (ttm) 145.38M
Shares Out 35.64M
EPS (ttm) 3.84
PE Ratio 41.41
Forward PE 36.90
Dividend n/a
Dividend Yield n/a
Trading Day February 25
Last Price $159.02
Previous Close $161.11
Change ($) -2.09
Change (%) -1.30%
Day's Open 161.60
Day's Range 158.51 - 162.49
Day's Volume 213,890
52-Week Range 58.72 - 177.12

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 2 weeks ago

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 4 weeks ago

What do they know, and how? By a community of over 100,000 worldwide employee information gatherers reporting back to Market-Maker HQ trading desks. Based on traders' hedges of short positions...

Business Wire - 1 month ago

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2020 financial results after the market cl...

Business Wire - 3 months ago

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference: Credit Suisse Healthcare Conference Da...

Seeking Alpha - 3 months ago

Medpace Holdings' (MEDP) CEO August Troendle on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

Medpace (MEDP) delivered earnings and revenue surprises of 4.63% and 2.74%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 3 months ago

Shares of Medpace Hldgs (NASDAQ:MEDP) moved lower by 1% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 53.52% year over year to $...

Business Wire - 3 months ago

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Financial Re...

Zacks Investment Research - 4 months ago

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 5 months ago

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2020 financial results after the market close on Monday, Oc...

Zacks Investment Research - 5 months ago

Top Ranked Momentum Stocks to Buy for August 28th

Other stocks mentioned: JYNT, LZB, NOVT
Business Wire - 5 months ago

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September: Baird's Global Healthcare...

Zacks Investment Research - 5 months ago

Top Ranked Momentum Stocks to Buy for August 26th

Other stocks mentioned: LZB, XPEL
Zacks Investment Research - 6 months ago

Top Ranked Momentum Stocks to Buy for August 24th

Other stocks mentioned: ISDR, LOW, ORLY
Zacks Investment Research - 6 months ago

Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 6 months ago

Top Ranked Momentum Stocks to Buy for August 20th

Other stocks mentioned: BIG, LCUT, URI
Zacks Investment Research - 6 months ago

The service sector index read 58.1% in July, a 17-month high. Lest we forget, a reading above 48.5% indicates expansion of the broader economy.

Other stocks mentioned: APAM, CLGX, FCN, HMHC
Zacks Investment Research - 6 months ago

Debt is something that gives you the chills since it brings with it the burden of repayment with additional interest in the future. So investors should choose stocks prudently

Other stocks mentioned: DSGX, LAKE, PDM, WST
Zacks Investment Research - 6 months ago

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.

Seeking Alpha - 6 months ago

Medpace Holdings, Inc. (MEDP) CEO August Troendle on Q2 2020 Results - Earnings Call Transcript

The Motley Fool - 6 months ago

The clinical trial company's second-quarter financial results were better than expected.

Investors Business Daily - 6 months ago

Medpace Holdings stock soared Tuesday to a record high after the provider of clinical testing and research services for drugmakers late Monday forecast better-than-expected revenue for 2020. T...

Zacks Investment Research - 6 months ago

Medpace (MEDP) delivered earnings and revenue surprises of 61.90% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 6 months ago

Medpace (MEDP) delivered earnings and revenue surprises of 52.38% and 13.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Investors Business Daily - 6 months ago

Medpace stock jumped in after-hours trading Monday, after rising in the regular session, as second-quarter revenue and full-year revenue guidance handily beat Wall Street expectations.

Benzinga - 6 months ago

Shares of Medpace Hldgs (NASDAQ:MEDP) moved higher by 15.7% in after-market trading after the company reported Q2 results.

Business Wire - 6 months ago

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2020.

Zacks Investment Research - 7 months ago

Medpace (MEDP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 7 months ago

Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kiplinger - 9 months ago

The last time value stocks were in style, Abraham Lincoln still had a Pennsylvania Avenue address.

Other stocks mentioned: ANET, FB, FIZZ, IBKR, ITT, SEIC, SIVB, TTWO, UNF
Seeking Alpha - 9 months ago

Medpace Holdings' (MEDP) CEO August Troendle on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 9 months ago

Medpace (MEDP) delivered earnings and revenue surprises of -1.30% and 1.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

Medpace Holdings, Inc. (MEDP) CEO August Troendle on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Medpace (MEDP) delivered earnings and revenue surprises of 13.33% and 3.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

The Stock Is Up Over 100% In 14 Months, Yet The Sentiment Is Still Bearish On Medpace Holdings

Zacks Investment Research - 1 year ago

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Motley Fool - 1 year ago

Helping people stricken with illness can be richly rewarding in more ways than one.

Other stocks mentioned: ARQL, ARWR, EIDX, GH, KOD, NEO, NVRO, THC, ZTS
The Motley Fool - 1 year ago

Many investors aren’t aware of the vital roles contract research organizations fulfill for pharmaceutical and biotech companies -- or of the billions they make each year for their services.

Other stocks mentioned: HCSG, IQV, PRAH, SYNH
Seeking Alpha - 1 year ago

Medpace Holdings, Inc. (MEDP) CEO August Troendle on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Medpace (MEDP) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Investment in mid-cap stocks is often recognized as a good portfolio diversification strategy during market fluctuations.

Other stocks mentioned: LAD, MRCY, PFSI, RH
Zacks Investment Research - 1 year ago

Nonfarm payroll reports show jobs addition in the private sector, these are five stocks to add to your portfolio.

Other stocks mentioned: FCN, FISV, GNW, HALL
Zacks Investment Research - 1 year ago

Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research - 1 year ago

As signs of deterioration emerge, the central bank may feel compelled to cut rate for the second time in September.

Other stocks mentioned: DVA, ILPT, TDS, UTL
Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor in Medpace Holdings, Inc. (MEDP).

Seeking Alpha - 1 year ago

New Medpace Holdings, Inc. (MEDP) CEO August Troendle on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research - 1 year ago

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Near-Term Outlook for Medical Services Industry Looks Bright

Other stocks mentioned: AMN, HQY
Seeking Alpha - 1 year ago

Medpace Holdings, Inc. (MEDP) CEO August Troendle on Q1 2019 Results - Earnings Call Transcript

About MEDP

Medpace Holdings provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigil... [Read more...]

Industry
Diagnostics & Research
IPO Date
Aug 11, 2016
CEO
August Troendle
Employees
3,600
Stock Exchange
NASDAQ
Ticker Symbol
MEDP
Full Company Profile

Financial Performance

In 2020, MEDP's revenue was $925.93 million, an increase of 7.54% compared to the previous year's $860.97 million. Earnings were $145.38 million, an increase of 44.74%.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for MEDP stock is "Buy." The 12-month stock price forecast is 164.50, which is an increase of 3.45% from the latest price.

Price Target
$164.50
(3.45% upside)
Analyst Consensus: Buy